Hot Keywords
rare disease orphan drug


Acknowledgment to Reviewers of Rare Disease and Orphan Drugs Journal

Published on: 3 Jan 2023 Viewed: 54

A rigorous and impartial peer-review process is essential for publication, which can help authors revise their papers in a timely manner and contribute to a sound academic environment. Here, we would like to sincerely thank every reviewer who dedicated time and professional skills to reviewing manuscripts for Rare Disease and Orphan Drugs Journal in 2022:

Sara Guerrero AspizuaSégolène AyméChristian Bailly
Jacques S. Beckmann Johannes BergerOlivier Blin
Sandra Arduim BrasilGillian Butler-BrowneSophie Christin-Maitre
Carroll CrossAngel CuestaIztok Dolenc
Mehmet Ali ErgünChristine FetroFrancesca Fioredda
Paola FortugnoEleni GavriilakiPaulo Ricardo Gazzola Zen
Nathalie GodefroidHolm GraessnerStephen Groft
Stephen C. GroftGijs van HaaftenUmur Hatipoglu
Gary HousleyTuula KallunkiThomas Kenny
Ágnes KinyóSatomi KitaAyca Kiykim
Austin LetcherHanns LochmüllerGert Matthijs
Toshiyuki NagasawaDaniel O'ConnorPaul Orchard
Federico PallardoPan PantziarkaAnne Pariser
David PearceNicoletta PedemonteManuel Posada
Xuping QinHua RenMiklós Sahin-Tõth
Judy SavigePeter SchmidtSusana Seixas
Paulo Victor Sgobbi SouzaJaspreet SinghVeronika Stoka
Violeta Stoyanova-BeninskaCharlie StrangeTönis Timmusk
Kazunori TobinoVito TurkJaymin Upadhyay
Lorena UrbanelliElvis ValeraMalgorzata Wygrecka

Thanks again to these reviewers for providing professional review reports for journal submissions!

For more information about preferential policies for journal reviewers, please contact our Editorial Office:

Respectfully Submitted by the Editorial Office
Rare Disease and Orphan Drugs Journal

© 2016-2023 OAE Publishing Inc., except certain content provided by third parties